JP2016534042A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534042A5 JP2016534042A5 JP2016521645A JP2016521645A JP2016534042A5 JP 2016534042 A5 JP2016534042 A5 JP 2016534042A5 JP 2016521645 A JP2016521645 A JP 2016521645A JP 2016521645 A JP2016521645 A JP 2016521645A JP 2016534042 A5 JP2016534042 A5 JP 2016534042A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- derived
- protein
- specific antigens
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361890054P | 2013-10-11 | 2013-10-11 | |
| US61/890,054 | 2013-10-11 | ||
| PCT/US2014/060180 WO2015054668A1 (en) | 2013-10-11 | 2014-10-10 | Ubiquitinylated proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534042A JP2016534042A (ja) | 2016-11-04 |
| JP2016534042A5 true JP2016534042A5 (https=) | 2017-11-24 |
| JP6636915B2 JP6636915B2 (ja) | 2020-01-29 |
Family
ID=52809877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016521645A Active JP6636915B2 (ja) | 2013-10-11 | 2014-10-10 | ユビキチニル化タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10226518B2 (https=) |
| EP (1) | EP3055322B1 (https=) |
| JP (1) | JP6636915B2 (https=) |
| KR (1) | KR20160127711A (https=) |
| CN (1) | CN105934442B (https=) |
| CA (1) | CA2926332A1 (https=) |
| WO (1) | WO2015054668A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104877017A (zh) * | 2015-05-06 | 2015-09-02 | 东南大学 | 一种抗肿瘤泛素化蛋白及其提取方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040241140A1 (en) * | 2000-11-01 | 2004-12-02 | Pavlakis George N. | Expression vectors able to elicit improved immune response and methods of using same |
| WO2007016340A2 (en) * | 2005-07-29 | 2007-02-08 | Providence Health System | Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response |
| WO2007058235A1 (ja) * | 2005-11-17 | 2007-05-24 | Medinet Co., Ltd. | 融合蛋白質およびその薬学的用途 |
| JP2012039877A (ja) * | 2009-04-10 | 2012-03-01 | Fukuoka Univ | ユビキチン融合遺伝子およびそれを用いたｄｎａワクチン |
| EP2608811B1 (en) * | 2010-08-27 | 2015-01-28 | Providence Health & Services - Oregon | Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates |
-
2014
- 2014-10-10 CN CN201480055567.7A patent/CN105934442B/zh active Active
- 2014-10-10 KR KR1020167012290A patent/KR20160127711A/ko not_active Ceased
- 2014-10-10 WO PCT/US2014/060180 patent/WO2015054668A1/en not_active Ceased
- 2014-10-10 US US14/512,322 patent/US10226518B2/en active Active
- 2014-10-10 EP EP14851719.6A patent/EP3055322B1/en active Active
- 2014-10-10 JP JP2016521645A patent/JP6636915B2/ja active Active
- 2014-10-10 CA CA2926332A patent/CA2926332A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016104045A5 (https=) | ||
| PH12016502406A1 (en) | Cell culture process for producing a protein | |
| PH12016502112A1 (en) | Method for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | |
| MX2021008142A (es) | Metodos para cosechar cultivos de celulas de mamifero. | |
| MY181513A (en) | Cell culture compositions and methods for polypeptide production | |
| WO2014146074A3 (en) | Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens | |
| MX376623B (es) | Cultivo celular metabolicamente optimizado. | |
| ZA201703241B (en) | Anti-c5 antibodies and methods of use | |
| PH12015501837B1 (en) | Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recombinant proteins | |
| EP4289944A3 (en) | Method for preparing genetically-modified t cells which express chimeric antigen receptor | |
| MX2015017110A (es) | Integracion dirigida. | |
| NZ715246A (en) | Improved process for production of monoclonal antibodies | |
| IL288819A (en) | Methods for cell culture and preparations for antibody production | |
| MX2022005389A (es) | Terapia de celulas t con receptor de antigeno quimerico. | |
| SG11201901495YA (en) | Method for producing antibody fusion protein | |
| MX366112B (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
| WO2016171224A9 (ja) | タンパク質の分泌生産法 | |
| SG10201809452RA (en) | Cell culture compositions with antioxidants and methods for polypeptide production | |
| MX2013005853A (es) | Enzimas de fusion que tienen actividad de n-acetilglucosaminil transferasa. | |
| EA201492185A1 (ru) | Способ получения рекомбинантной идуронат-2-сульфатазы | |
| SG11202009216YA (en) | Total afucosylated glycoforms of antibodies produced in cell culture | |
| MX2018004580A (es) | Metodo para producir proteina de fusion con dominio fc de igg. | |
| WO2014152524A3 (en) | Novel method of protein purification | |
| EA201992828A1 (ru) | Способы культивирования клеток | |
| JP2016534042A5 (https=) |